Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats

Hepatology Research

Volumn 38, Issue 9, 2008, Pages 930-939

  Kanemura, Hironari ^a   Iimuro, Yuji ^a   Takeuchi, Masaharu ^a   Ueki, Takahiro ^a   Hirano, Tadamichi ^a   Horiguchi, Kiyoshi ^a   Asano, Yasukane ^a   Fujimoto, Jiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Hepatocyte growth factor; Liver fibrosis; Matrix metalloproteinase; Naked plasmid DNA; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA GALACTOSIDASE; COLLAGENASE 3; DIMETHYLNITROSAMINE; HYDROXYPROLINE; NAKED DNA; PLASMID DNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; HISTOPATHOLOGY; LIVER FIBROSIS; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

EID: 48949092177     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00340.x     Document Type: Article

References (38)

1. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-50.
2. Pinzani M, Romanelli RG, Magli S. Progression of fibrosis in chronic liver diseases: Time to tally the score. J Hepatol 2001; 34: 764-7.
3. Miyazawa K, Tsubouchi H, Naka D et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-73.
4. Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3.
5. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3: 67-85.
6. Boros P, Miller CM. Hepatocyte growth factor: A multifunctional cytokine. Lancet 1995; 345: 293-5.
7. Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-30.
8. Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K, Kaneda Y. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): Reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 1997; 8: 2133-41.
9. Kaneda Y, Saeki Y, Morishita R. Gene therapy using HVJ-liposomes: The best of both worlds? Mol Med Today 1999; 5: 298-303.
10. Niidome T, Huang L. Gene therapy progress and prospects: Nonviral vectors. Gene Ther 2002; 9: 1647-52.
11. Crystal RG. Transfer of genes to humans: Early lessons and obstacles to success. Science 1995; 270: 404-10.
12. Zhang G, Vargo D, Budker V, Armstrong N, Knechtle S, Wolff JA. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum Gene Ther 1997; 8: 1763-72.
13. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967; 19: 249-55.
14. Inayama S, Shibata T, Ohtsuki J, Saito S. A new microanalytical method for determination of hydroxyproline in connective tissues. Keio J Med 1978; 27: 43-6.
15. Watanabe T, Niioka M, Hozawa S et al. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 2000; 33: 224-35.
16. Higashiyama R, Inagaki Y, Hong YY et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007; 45: 213-22.
17. Vater CA, Nagase H, Harris ED Jr. Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. J Biol Chem 1983; 258: 9374-82.
18. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992; 267: 3581-4.
19. Chin JR, Murphy G, Werb Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem 1985; 260: 12367-76.
20. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 1986; 261: 14245-55.
21. Okada Y, Konomi H, Yada T, Kimata K, Nagase H. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 1989; 244: 473-6.
22. Iredale JP, Benyon RC, Pickering J et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-49.
23. Emonard H, Grimaud JA. Matrix metalloproteinases. A review. Cell Mol Biol 1990; 36: 131-53.
24. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636-42.
25. Matsuda Y, Matsumoto K, Yamada A et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/ cirrhosis. Hepatology 1997; 26: 81-9.
26. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357-61.
27. Hara T, Tan Y, Huang L. In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector. Proc Natl Acad Sci USA 1997; 94: 14547-52.
28. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-66.
29. Budker V, Zhang G, Knechtle S, Wolff JA. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther 1996; 3: 593-8.
30. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
31. Iimuro Y, Nishio T, Morimoto T et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003; 124: 445-58.
32. Ozaki I, Zhao G, Mizuta T et al. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 2002; 36: 169-78.
33. Ozaki I, Mizuta T, Zhao G et al. Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1. Hepatol Res 2003; 27: 289-301.
34. Sherriff-Tadano R, Ohta A, Morito F et al. Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism. Mod Rheumatol 2006; 16: 364-71.
35. Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G, LaRochelle WJ. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 1996; 7: 1513-23.
36. Takayama H, LaRochelle WJ, Sharp R et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 1997; 94: 701-6.
37. Santoni-Rugiu E, Preisegger KH, Kiss A et al. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 1996; 93: 9577-82.
38. Morishita R, Aoki M, Hashiya N et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004; 44: 203-9.